Dot Health, a mobile platform that finds and stores medical records, and Maple, a platform for on-demand access to healthcare providers, have partnered to create a virtual healthcare solution.

Based in San Francisco, IndieBio is a 4 month biotech accelerator program that provides $250k funding, lab space and mentorship.

The UTEST Program provides support to University of Toronto entrepreneurs by providing companies with investment capital, mentoring, business strategy and incubation space at the University of Toronto St. George Campus.

XPan was the winner of FACIT’s annual Falcons’ Fortunes pitch competition, receiving the $50,000 Ernsting Entrepreneurship Award.

Fusion Pharmaceuticals announced the completion of a $105 million Series B financing led by Varian and new investor OrbiMed. 

AceAge was named the winner of the 2019 CABHI/MaRS Pitch Competition Award for Innovation in Aging during Health Innovation Week.

Mariner Endosurgery has partnered with the University at Buffalo (UB) to establish the first U.S. site of their LaparoGuard Augmented Surgical System.

As the world’s largest biotechnology event, the BIO International Convention's Start-Up Stadium is designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, and BIO attendees. 

Epineuron was named the grand prize winner of the 6th Annual Synapse Life Science Competition, taking home a prize of $25,000 in cash and in-kind prizes.

CoHealth has announced the launch of CoHealth 2.0, its upgraded application aimed to help simplify the user experience, as well as improve coordination and management.

The University of Toronto has received its largest ever donation, a $100-million gift to further the school’s research on artificial intelligence.

Vena Medical published a pre-clinical study of their novel microangioscope in the Journal of NeuroInterventional Surgery.

Nanology Labs and Cohesys won first place prizes in their respective categories at the 2019 RBC Prize for Innovation and Entrepreneurship pitch competition.

MIMOSA CEO Dr. Karen Cross was profiled in 'Women of Influence' for her work as a scientist, surgeon and entrepreneur.

Ovensa announced a collaboration agreement with Takeda Pharmaceutical Company Limited to evaluate TRIOZAN™, Ovensa's proprietary nanomedicine platform.

Synaptive Medical, a global pioneer in automated surgical planning and robotics, announced the appointment of Sandra Clarke, CPA, CMA as Chief Financial Officer.

Thornhill Medical's ClearMate device, which helps treat patients suffering from carbon monoxide poisoning, was approved for marketing by the FDA.